Does a Mandatory Non- medical Switch from Originator to Biosimilar Etanercept Lead to Increase in Healthcare Use and Costs? A Danish Register- based Study of 1620 Patients with Infl ammatory Arthritis

Bente Glintborg, R. Ibsen, R. E. Q. Bilbo, Merete Lund Hetland, J. Kjellberg

OriginalsprogEngelsk
Artikelnummer0205
TidsskriftArthritis & Rheumatology
Vol/bind71
Udgave nummerS10
Antal sider3
ISSN1537-2960
StatusUdgivet - 2019

Citationsformater